Sandostatin
Active Ingredient(s): OctreotideFDA Approved: * October 21, 1988
Pharm Company: * NOVARTIS
Category: Cancer
Octreotide, sold under the brand name Sandostatin (marketed by Novartis) among others, is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. It was first synthesized in 1979 by the chemist Wilfried Bauer, and binds predominantly to the somatostatin receptors SSTR2 and SSTR5.[3] It was approved for use in the United States in 1988.[2][1... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.1 Discussion
Dosage List
Sandostatin 50 ug/ml Intravenous; Subcutaneous Injection, Solution
NDC: 0078-0180
Labeler:
Novartis Pharmaceuticals Corporation
Sandostatin 100 ug/ml Intravenous; Subcutaneous Injection, Solution
NDC: 0078-0181
Labeler:
Novartis Pharmaceuticals Corporation
Sandostatin 500 ug/ml Intravenous; Subcutaneous Injection, Solution
NDC: 0078-0182
Labeler:
Novartis Pharmaceuticals Corporation
Sandostatin 200 ug/ml Intravenous; Subcutaneous Injection, Solution
NDC: 0078-0183
Labeler:
Novartis Pharmaceuticals Corporation
Sandostatin 1000 ug/ml Intravenous; Subcutaneous Injection, Solution
NDC: 0078-0184
Labeler:
Novartis Pharmaceuticals Corporation
Related Brands
Drugs with the same active ingredientsPopular Topics
doctors who prescribe sandostatin in cincinnati
1 REPLY
My sister is going back to Cincinnati and needs to find a doctor who can prescribe Sandostatin IV's each month ## He...
1 REPLY